All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

The effect of chelator type on in vitro receptor binding and stability in Lu-177-labeled cetuximab and panitumumab

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F14%3A33150923" target="_blank" >RIV/61989592:15110/14:33150923 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11160/14:10281947

  • Result on the web

    <a href="http://dx.doi.org/10.1002/jlcr.3204" target="_blank" >http://dx.doi.org/10.1002/jlcr.3204</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1002/jlcr.3204" target="_blank" >10.1002/jlcr.3204</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    The effect of chelator type on in vitro receptor binding and stability in Lu-177-labeled cetuximab and panitumumab

  • Original language description

    Monoclonal antibodies are used in the therapy of various diseases. Thanks to their high specific uptake in target tissues, these antibodies can be utilized in targeted radioimmunotherapy as carriers of radioisotopes to tumors. However, important characteristics of antibodies such as target binding and stability in the organism may be affected by various structural parameters. This study has focused on the potential influence of selected chelators on radiochemical quality and in vitro receptor binding capacity in two modified monoclonal antibodies-cetuximab and panitumumab, both ligands of the epidermal growth factor receptor (EGFR). These two antibodies were each coupled with three macrocyclic chelators (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1,4,7-triazacyclononane-1,4,7-triacetic acid, and 3,6,9,15-tetraazabicyclo[9.3.1]-pentadeca-1(15),11,13-triene-4-(S)-(4-isothiocyanatobenzyl)-3,6,9-triacetic acid) and labeled with lutetium-177. The stability of the preparations

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2014

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of labelled compounds & radiopharmaceuticals

  • ISSN

    0362-4803

  • e-ISSN

  • Volume of the periodical

    57

  • Issue of the periodical within the volume

    7

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    5

  • Pages from-to

    448-452

  • UT code for WoS article

    000340168900002

  • EID of the result in the Scopus database